Extendicare Inc.
EXETF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $933 | $618 | $581 | $654 |
| - Cash | $122 | $75 | $167 | $105 |
| + Debt | $292 | $335 | $384 | $537 |
| Enterprise Value | $1,104 | $877 | $798 | $1,086 |
| Revenue | $1,466 | $1,305 | $1,222 | $1,167 |
| % Growth | 12.4% | 6.8% | 4.7% | – |
| Gross Profit | $1,466 | $168 | $77 | $116 |
| % Margin | 100% | 12.8% | 6.3% | 9.9% |
| EBITDA | $155 | $99 | $49 | $75 |
| % Margin | 10.6% | 7.6% | 4% | 6.4% |
| Net Income | $75 | $34 | $70 | $12 |
| % Margin | 5.1% | 2.6% | 5.7% | 1% |
| EPS Diluted | 0.86 | 0.4 | -0.053 | 0.11 |
| % Growth | 115% | 860.5% | -147.8% | – |
| Operating Cash Flow | $144 | $23 | $99 | $63 |
| Capital Expenditures | -$42 | -$129 | -$102 | -$70 |
| Free Cash Flow | $102 | -$106 | -$3 | -$6 |